Treatment of APOE4-tauopathy mice with HMGB1 inhibitors effectively blocked the intraneuronal translocation and release of HMGB1 and ameliorated APOE4-driven Alzheimer’s disease pathologies. The gene discussed is HMGB1; the disease is early-onset autosomal dominant Alzheimer disease.